Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to -$7.1 million.

  • Conmed's Cash from Investing Activities fell 7601.49% to -$7.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$21.0 million, marking a year-over-year decrease of 6016.51%. This contributed to the annual value of -$21.0 million for FY2025, which is 6016.51% down from last year.
  • Latest data reveals that Conmed reported Cash from Investing Activities of -$7.1 million as of Q4 2025, which was down 7601.49% from -$5.2 million recorded in Q3 2025.
  • In the past 5 years, Conmed's Cash from Investing Activities ranged from a high of -$2.0 million in Q1 2024 and a low of -$148.3 million during Q2 2022
  • For the 5-year period, Conmed's Cash from Investing Activities averaged around -$15.9 million, with its median value being -$4.6 million (2023).
  • Per our database at Business Quant, Conmed's Cash from Investing Activities plummeted by 919166.67% in 2021 and then skyrocketed by 9627.09% in 2023.
  • Over the past 5 years, Conmed's Cash from Investing Activities (Quarter) stood at -$3.2 million in 2021, then tumbled by 98.18% to -$6.3 million in 2022, then increased by 23.16% to -$4.9 million in 2023, then increased by 16.79% to -$4.0 million in 2024, then crashed by 76.01% to -$7.1 million in 2025.
  • Its Cash from Investing Activities was -$7.1 million in Q4 2025, compared to -$5.2 million in Q3 2025 and -$5.7 million in Q2 2025.